Senior patient leadership, built from decades on the inside.

Chief Patient Officer expertise, brought in at the moment it matters most.

Tiffany Patrick, founder of Health Advocacy Strategies

Patient and caregiver experience as essential business context, brought into the decisions that happen long before launch.

I'm Tiffany Patrick, founder of Health Advocacy Strategies. I have spent more than 25 years in life sciences, across drug development, commercialization, and enterprise value creation. Most recently I served as Chief Patient Officer at Amicus Therapeutics, leading Patient and Professional Advocacy as an enterprise function.

Find me on LinkedIn
25+ Years

Across drug development, commercialization, and value creation in oncology, rare disease, CNS, cardio-metabolic, and specialty markets.

Company Lifecycle Experience

From preclinical and clinical-stage growth to launch readiness, label expansion, post-approval strategy, and complex transition moments.

Patient Enterprise Scaling

Building the leadership systems, operating models, culture, and engagement discipline that allow patient enterprise to grow with the company.

AI-Enabled Intelligence

Using AI-enabled mapping, intelligence, and insight capture to measure, integrate, and scale patient enterprise as the organization learns.

My Areas of expertise
OncologyRare DiseaseCNS, Cardio-Metabolic & Specialty MarketsRNAi & Novel ModalitiesLifecycle StrategyPatient Enterprise ScalingAI-Enabled IntelligencePatient-Dedicated CultureOncologyRare DiseaseCNS, Cardio-Metabolic & Specialty MarketsRNAi & Novel ModalitiesLifecycle StrategyPatient Enterprise ScalingAI-Enabled IntelligencePatient-Dedicated Culture

Frequently Asked Questions

Got questions? We’ve got answers.

What does a fractional Chief Patient Officer actually do?

I bring Patient Enterprise leadership into your organization on a part-time basis. That means setting the strategy for how patient context informs your decisions, building the operating model and internal culture to sustain it, and sitting at the leadership table as Patient Enterprise evolves. The scope flexes to what your business needs, from a focused engagement to ongoing enterprise leadership.

How is this different from hiring a consultant or an agency?

A consultant delivers a recommendation and leaves. An agency executes campaigns. I operate as part of your leadership, accountable for outcomes rather than deliverables. My background is 25 years inside life sciences companies, most recently as Chief Patient Officer at Amicus Therapeutics, so I build leadership, culture, systems, and reltionships that hold after the engagement ends.

When should we bring you in?

The earlier patient context shapes your decisions, the more it strengthens them. I work with companies across the lifecycle, from preclinical and clinical-stage through launch readiness, label expansion, and complex transition moments. If you are making decisions that impact patients and weighing whether patient context belongs in the room, that is usually the sign it does.

What if we later want to hire a full-time Chief Patient Officer?

That is often the right outcome, and I help you get there. Part of the work is building the leadership systems and internal capability that make a permanent hire successful, and I can help define the role, shape the search, and hand off cleanly. The goal is a patient enterprise that grows with your company, whether I stay involved or not.

What is Health Advocacy Strategies?

Health Advocacy Strategies is a fractional patient leadership practice for life sciences companies, founded by Tiffany Patrick. Drawing on more than 25 years in the industry, most recently as Chief Patient Officer at Amicus Therapeutics, the practice brings senior patient enterprise leadership to biotech and pharma leadership teams across the product lifecycle, from clinical-stage development through launch and label expansion, so patient context shapes the decisions that matter.

Let's get started

Build patient enterprise before you need to retrofit it.

Most engagements begin with a focused strategy conversation about your company’s stage, science, community context, and near-term decisions.